Загрузка...
Temozolomide for immunomodulation in the treatment of glioblastoma
Temozolomide is the most widely used chemotherapy for patients with glioblastoma (GBM) despite the fact that approximately half of treated patients have temozolomide resistance and all patients eventually fail therapy. Due to the limited efficacy of existing therapies, immunotherapy is being widely...
Сохранить в:
| Опубликовано в: : | Neuro Oncol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6231207/ https://ncbi.nlm.nih.gov/pubmed/29733389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy072 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|